Evidence map›Paper›PMID 29857548›Full record

ArticleCells2018

B Cells and B Cell Blasts Withstand Cryopreservation While Retaining Their Functionality for Producing Antibody.

Philipp Fecher, Richard Caspell, Villian Naeem, Alexey Y Karulin, Stefanie Kuerten, Paul V Lehmann

Open access · goldAbstract read
In one paragraph

Article in Cells, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 31 citations in OpenAlex.

  1. InterferonFrontiers in immunology · 2020
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Philipp FecherResearch & Development Department, Cellular Technology Limited, Shaker Heights, OH 44122, USA. philipp-fecher@t-online.de.
Richard CaspellResearch & Development Department, Cellular Technology Limited, Shaker Heights, OH 44122, USA. richard.caspell@immunospot.com.
Villian NaeemResearch & Development Department, Cellular Technology Limited, Shaker Heights, OH 44122, USA. villian.naeem@immunospot.com.
Alexey Y KarulinResearch & Development Department, Cellular Technology Limited, Shaker Heights, OH 44122, USA. alexey.karulin@immunospot.com.
Stefanie KuertenInstitute of Anatomy and Cell Biology, Friedrich-Alexander University Erlangen-Nürnberg, 91054 Erlangen, Germany. stefanie.kuerten@fau.de.ORCID 0000-0001-6119-605X
Paul V LehmannResearch & Development Department, Cellular Technology Limited, Shaker Heights, OH 44122, USA. paul.lehmann@immunospot.com.
Friedrich-Alexander-Universität Erlangen-Nürnberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In individuals who have once developed humoral immunity to an infectious/foreign antigen, the antibodies present in their body can mediate instant protection when the antigen re-enters. Such antigen-specific antibodies can be readily detected in the serum. Long term humoral immunity is, however, also critically dependent on the ability of memory B cells to engage in a secondary antibody response upon re-exposure to the antigen. Antibody molecules in the body are short lived, having a half-life of weeks, while memory B cells have a life span of decades. Therefore, the presence of serum antibodies is not always a reliable indicator of B cell memory and comprehensive monitoring of humoral immunity requires that both serum antibodies and memory B cells be assessed. The prevailing view is that resting memory B cells and B cell blasts in peripheral blood mononuclear cells (PBMC) cannot be cryopreserved without losing their antibody secreting function, and regulated high throughput immune monitoring of B cell immunity is therefore confined to-and largely limited by-the need to test freshly isolated PBMC. Using optimized protocols for freezing and thawing of PBMC, and four color ImmunoSpot

Indexed as

antibodiesantibody-secreting cellsantibody secretionfour color B cell ELISPOTfreeze-thawing PBMCIgAIgDIgEIgG1IgG2IgG3IgG4IgMimmune monitoringimmunoglobulin classes and subclassesimmunoglobulinsmultiplex immune assayplasma cells

Identifiers

PMID29857548
PMCPMC6028916
OpenAlexW2805195299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.